X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Pfizer with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ADCOCK INGRAM (S. Africa) - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PFIZER   ADCOCK INGRAM
EQUITY SHARE DATA
    PFIZER
Mar-17
ADCOCK INGRAM
Jun-14
PFIZER/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs2,055360-   
Low Rs1,651259-   
Sales per share (Unadj.) Rs429.8107.0-  
Earnings per share (Unadj.) Rs73.6-27.0-  
Cash flow per share (Unadj.) Rs87.4-22.3-  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs528.784.0-  
Shares outstanding (eoy) m45.75168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.32.9 149.0%   
Avg P/E ratio x25.2-11.5 -219.2%  
P/CF ratio (eoy) x21.2-13.9 -153.1%  
Price / Book Value ratio x3.53.7 95.1%  
Dividend payout %27.20-   
Avg Mkt Cap Rs m84,77752,238 162.3%   
No. of employees `0002.84.3 66.1%   
Total wages/salary Rs m3,0393,279 92.7%   
Avg. sales/employee Rs Th6,925.94,205.5 164.7%   
Avg. wages/employee Rs Th1,070.4763.7 140.2%   
Avg. net profit/employee Rs Th1,186.3-1,059.7 -111.9%   
INCOME DATA
Net Sales Rs m19,66318,054 108.9%  
Other income Rs m1,012126 800.1%   
Total revenues Rs m20,67418,181 113.7%   
Gross profit Rs m3,491-3,129 -111.6%  
Depreciation Rs m629779 80.8%   
Interest Rs m10489 2.0%   
Profit before tax Rs m3,864-4,271 -90.5%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m1,3040-   
Tax Rs m1,801267 674.8%   
Profit after tax Rs m3,368-4,549 -74.0%  
Gross profit margin %17.8-17.3 -102.5%  
Effective tax rate %46.6-6.2 -745.8%   
Net profit margin %17.1-25.2 -68.0%  
BALANCE SHEET DATA
Current assets Rs m20,78913,223 157.2%   
Current liabilities Rs m7,8707,440 105.8%   
Net working cap to sales %65.732.0 205.1%  
Current ratio x2.61.8 148.6%  
Inventory Days Days60111 53.9%  
Debtors Days Days22124 18.1%  
Net fixed assets Rs m9,1757,708 119.0%   
Share capital Rs m45884 545.8%   
"Free" reserves Rs m23,7310-   
Net worth Rs m24,18914,171 170.7%   
Long term debt Rs m254,980 0.5%   
Total assets Rs m32,70626,770 122.2%  
Interest coverage x403.5-7.7 -5,218.4%   
Debt to equity ratio x00.4 0.3%  
Sales to assets ratio x0.60.7 89.1%   
Return on assets %10.3-15.2 -68.1%  
Return on equity %13.9-32.1 -43.4%  
Return on capital %21.4-19.8 -108.0%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-4,0040-   
CASH FLOW
From Operations Rs m3,2881,541 213.4%  
From Investments Rs m-2,496-473 527.6%  
From Financial Activity Rs m-8264,520 -18.3%  
Net Cashflow Rs m-355,587 -0.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.96 Rs / ZAR

Compare PFIZER With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare PFIZER With: FRESENIUS KABI ONCO.  DR. DATSONS LABS  TORRENT PHARMA  BIOCON LTD  FULFORD INDIA  



Today's Market

Sensex Ends 262 Points Lower; Metal & Realty Stocks Fall(Closing)

Indian share markets ended lower today amid weak global cues. At the closing bell, the BSE Sensex finished lower by 262 points.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Jun 19, 2018 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS